Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
Revenues | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Cost of goods sold | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, general and administrative [+] | | | 16.0 | 15.1 | 12.6 | 6.9 | 5.0 | 4.0 |
General and administrative | | | 16.0 | 15.1 | 12.6 | 6.9 | 5.0 | 4.0 |
Research and development | | | 1.2 | 14.1 | 15.0 | 15.0 | 14.9 | 8.6 |
Other operating expenses | | | -3.3 | | | | | |
EBITDA [+] | | | -13.9 | -29.2 | -27.6 | -21.8 | -19.9 | -12.6 |
EBITDA growth | | | -30.1% | 131.8% | | | | |
Depreciation and amortization | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EBIT [+] | | | -13.9 | -29.2 | -27.6 | -21.8 | -19.9 | -12.6 |
EBIT growth | | | -30.1% | 131.8% | | | | |
Interest expense | | | | | | 1.1 | 1.3 | 1.0 |
Interest expense | | | | | | 1.1 | 1.3 | 1.0 |
Other income (expense), net [+] | | | -1.8 | | | 1.5 | 0.0 | |
Change in fair value of warrants | | | | | 1.4 | -1.5 | 0.0 | |
Other | | | | | | 0.7 | -1.0 | |
Pre-tax income | | | -15.9 | -28.2 | -27.0 | -21.5 | -21.2 | -13.6 |
Income taxes | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | | | -15.9 | -28.2 | -27.0 | -21.5 | -21.2 | -13.6 |
|
Basic EPS [+] | | | ($0.83) | ($1.57) | ($1.64) | ($1.39) | ($1.44) | ($0.98) |
Growth | | | -42.5% | 60.2% | | | | |
Diluted EPS [+] | | | ($0.83) | ($1.57) | ($1.64) | ($1.39) | ($1.44) | ($0.98) |
Growth | | | -42.5% | 60.2% | | | | |
|
Shares outstanding (basic) [+] | | | 19.1 | 17.9 | 16.5 | 15.5 | 14.7 | 13.9 |
Growth | | | 30.1% | 29.1% | | | | |
Shares outstanding (diluted) [+] | | | 19.1 | 17.9 | 16.5 | 15.5 | 14.7 | 13.9 |
Growth | | | 30.1% | 29.1% | | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|